Cited by 234Liver Disease Diagnosis and TreatmentMitochondrial Function and PathologyDrug-Induced Hepatotoxicity and Protection

Mitochondria in non-alcoholic fatty liver disease

Open access
Simões, Inês C.M., Fontes, Adriana, Pinton, Paolo, Zischka, Hans, Wieckowski, Mariusz R.·2018·The International Journal of Biochemistry & Cell Biology

Abstract

NAFLD is a common disease in Western society and ranges from steatosis to steatohepatitis and to end-stage liver disease. The molecular mechanisms that cause the progression of steatosis to severe liver damage are not fully understood. One suggested mechanism involves the oxidation of biomolecules by mitochondrial ROS which initiates a vicious cycle of exacerbated mitochondrial dysfunction and increased hepatocellular oxidative damage. This may ultimately pave the way for hepatic inflammation and liver failure. This review updates our current understanding of mitochondria-derived oxidative stress in the progression of NAFLD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biocel.2017.12.019

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Disruption in complexes I and III increases formation of ROS, diminishes tGSH, and depletes ATP generation.

    “Disruption in the complexes I and III has shown to increase formation of ROS, diminish tGSH, and deplete ATP generation [42].”

    From Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells (2021) · cites this paper as [42]

    Section 2.2.2 identifies complexes I and III as major sites of superoxide production and reports diminished GSH-related antioxidant activity in NAFLD. Section 2.1.2 reports reduced ATP synthesis alongside ETC alterations. The paper does not establish that disruption of complexes I and III specifically causes all three effects, or that total glutathione (tGSH) is depleted. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Simões, I. C. M., Fontes, A., Pinton, P., Zischka, H., & Wieckowski, M. R.
Affiliations
  • Instytut Biologii Doświadczalnej im. Marcelego Nenckiego (PL)
  • Helmholtz Munich (DE)
  • University of Ferrara (IT)
Corresponding author
Wieckowski, Mariusz R.
Venue
The International Journal of Biochemistry & Cell Biology
Publisher
Elsevier BV
Published
2018-02
Volume
95
Pages
93-99
ISSN
1357-2725 (ISSN-L)
OpenAlex
W2777277563
Cited by
234
References
2
Citations by year
2026: 5 · 2025: 16 · 2024: 24 · 2023: 32 · 2022: 37 · 2021: 50 · 2020: 25 · 2019: 29 · 2018: 15 · 2012: 1
FWCI
2.50
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Biochemistry & Cell Biology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by-nc-nd)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
  • Site cant be reached (submittedVersion, cc-by-nc-nd)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by-nc-nd)
Funders
  • FOIE GRAS
  • mtFOIE GRAS
  • European Union’s Horizon 2020 Research and Innovation programme (722619, 734719)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
non-alcoholic fatty liver disease, mitochondria, mitochondrial dysfunction, reactive oxygen species, oxidative stress, steatosis, steatohepatitis, liver inflammation, disease progression
MeSH terms
Animals, Humans, Mitochondria, Liver, Oxidation-Reduction, Severity of Illness Index, Reactive Oxygen Species, Oxidative Stress, Disease Progression, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review